Luis María
Lezama Diago
Universidad Nacional de La Plata
La Plata, ArgentinaPublications en collaboration avec des chercheurs de Universidad Nacional de La Plata (24)
2022
2017
-
Evidence of promising biological-pharmacological activities of the sertraline-based copper complex: (SerH2)2[CuCl4]
Journal of Inorganic Biochemistry, Vol. 174, pp. 76-89
2016
-
Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin
Bioorganic and Medicinal Chemistry, Vol. 24, Núm. 18, pp. 4108-4119
-
Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin
Journal of Inorganic Biochemistry, Vol. 157, pp. 80-93
-
Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)–irbesartan complex: structure–antihypertensive activity relationships in Cu(II)–sartan complexes
Journal of Biological Inorganic Chemistry, Vol. 21, Núm. 7, pp. 851-863
2015
-
Anti-thyroid and antifungal activities, BSA interaction and acid phosphatase inhibition of methimazole copper(II) complexes
Chemico-Biological Interactions, Vol. 229, pp. 64-72
-
Insights into the mechanisms underlying the antitumor activity of an oxidovanadium(IV) compound with the antioxidant naringenin. Albumin binding studies
Journal of Inorganic Biochemistry, Vol. 149, pp. 12-24
2014
-
Antitumoral, antihypertensive, antimicrobial, and antioxidant effects of an octanuclear copper(II)-telmisartan complex with an hydrophobic nanometer hole
Inorganic Chemistry, Vol. 53, Núm. 11, pp. 5724-5737
-
Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV) complex of chlorogenic acid. Synthesis, characterization and spectroscopic examination on the transport mechanism with bovine serum albumin
Journal of Inorganic Biochemistry, Vol. 135, pp. 86-99
2013
-
Biological evaluation of morin and its new oxovanadium(IV) complex as antio-xidant and specific anti-cancer agents
Chemico-Biological Interactions, Vol. 206, Núm. 2, pp. 289-301
-
Improvement of the antihypertensive capacity of candesartan and trityl candesartan by their SOD mimetic copper(II) complexes
Journal of Inorganic Biochemistry, Vol. 123, pp. 23-33
-
Inhibition behavior on alkaline phosphatase activity, antibacterial and antioxidant activities of ternary methimazole-phenanthroline-copper(II) complex
Inorganica Chimica Acta, Vol. 405, pp. 243-251
2012
-
Antioxidant activity of methimazole-copper(II) bioactive species and spectroscopic investigations on the mechanism of its interaction with Bovine Serum Albumin
Polyhedron, Vol. 31, Núm. 1, pp. 530-538
2011
-
Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex
Journal of Biological Inorganic Chemistry, Vol. 16, Núm. 4, pp. 653-668
2010
-
Copper(II) complexes of methimazole, an anti Grave's disease drug. Synthesis, characterization and its potential biological behavior as alkaline phosphatase inhibitor
BioMetals, Vol. 23, Núm. 2, pp. 255-264
-
Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: Relationship with the radical scavenger activity
Journal of Biological Inorganic Chemistry, Vol. 15, Núm. 6, pp. 889-902
-
Spectroscopic evidence on the interaction of prephenate, a shikimate pathway intermediate, with oxidovanadium(IV) species
Inorganica Chimica Acta, Vol. 363, Núm. 7, pp. 1593-1596
2009
-
Synthesis, chemical speciation and SOD mimic assays of tricarballylic acid-copper(II) and imidazole-tricarballylic acid-copper(II) complexes
Journal of Inorganic Biochemistry, Vol. 103, Núm. 2, pp. 219-226
2007
-
Losartan and its interaction with copper(II): Biological effects
Bioorganic and Medicinal Chemistry, Vol. 15, Núm. 19, pp. 6418-6424
-
Molecular structure, bioavailability and bioactivity of [Cu(o-phen)2(cnge)](NO3)2 · 2H2O and [Cu(o-phen)(cnge)(H2O)(NO3)2] complexes
Journal of Inorganic Biochemistry, Vol. 101, Núm. 5, pp. 741-749